Diabetes Care Devices - Egypt | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Egypt is projected to reach US$112.90m in 2024.
Revenue is expected to demonstrate an annual growth rate (CAGR 2024-2029) of 15.97%, which will result in a market volume of US$236.80m by 2029.
In a global comparison, the majority of revenue will be generated the United States, where it is anticipated to reach US$11.71bn in 2024.
In Egypt, the increasing prevalence of diabetes is driving demand for innovative diabetes care devices, highlighting the need for enhanced patient management solutions.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Egypt is witnessing moderate growth, influenced by factors such as the increasing prevalence of diabetes, rising health awareness, and advancements in technology that enhance patient management and monitoring capabilities.

Customer preferences: In Egypt, there is a noticeable shift towards personalized diabetes management solutions, driven by a growing awareness of the disease's impact on daily life. Consumers are increasingly interested in advanced glucose monitoring devices that offer real-time data and connectivity to mobile applications, facilitating better self-management. Additionally, the rise of telehealth services is empowering patients with convenient access to healthcare professionals, reflecting a cultural shift towards proactive health management. This trend is further accentuated by the younger demographic's inclination towards technology-driven health solutions.

Trends in the market: In Egypt, the Diabetes Care Devices Market is experiencing a notable transformation characterized by the increasing adoption of continuous glucose monitoring (CGM) systems and insulin delivery devices. Patients are seeking solutions that provide seamless integration with smartphones and wearable technology, promoting real-time data access and personalized care. Moreover, the expansion of telehealth services is enhancing patient engagement, allowing for remote consultations and continuous support from healthcare professionals. This shift not only empowers patients but also signifies a growing demand for innovative solutions, prompting industry stakeholders to invest in advanced technologies and strategic partnerships to meet evolving consumer needs.

Local special circumstances: In Egypt, the Diabetes Care Devices Market is shaped by unique cultural attitudes towards health management and a strong emphasis on traditional medicine. The rising prevalence of diabetes is prompting increased awareness, leading to a demand for modern monitoring and management solutions. Additionally, regulatory frameworks that support innovation in medical technology are paving the way for local startups to develop tailored solutions. Geographically, urban centers are experiencing quicker adoption of advanced devices, while rural regions face challenges in accessibility, necessitating targeted outreach programs to bridge the gap.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Egypt is significantly impacted by macroeconomic factors such as the national economic climate, healthcare spending, and demographic trends. With the rising prevalence of diabetes, the government is increasing its investment in healthcare infrastructure, facilitating access to innovative medical devices. Favorable fiscal policies aimed at promoting public-private partnerships are encouraging local startups to innovate solutions tailored to Egyptian needs. Additionally, global economic trends, such as the shift towards preventive healthcare, are influencing consumer demand for advanced diabetes management tools, particularly in urban areas where awareness is growing.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.